Delirium in Old Age, Hospital Acquired Condition, Muscle Atrophy or Weakness, Muscle Loss, Physical Disability, Physical Inactivity, Weakness, Muscle
Conditions
Keywords
Artificial Intelligence (AI), Physical Therapy, Hospitalization related muscle atrophy, Hospitalization associated decline, Inpatient rehabilitation, AI driven physical therapy
Brief summary
Patients admitted to the hospital often develop functional impairments due to being in bed most of the day. Each day of bedrest leads to significant muscle loss. As a result, many patients become dependent on others or require rehabilitation at a facility to improve mobility and function prior to returning home. Staff in the hospital is limited and often unable to mobilize patients every day while hospitalized. The investigators are testing a new experimental gamified physical therapy exercise software to see if it can be a fun, enjoyable way to help mobilize patients without the assistance of staff. The primary aim of this pilot/proof of concept study is to determine whether gamified physical therapy software can help inpatients exercise within the safety of their own beds and preserve pre-hospitalization function.
Interventions
Physical Therapy software via a computer/monitor will be set up for the patient. It will begin with a tutorial video for different exercises in the form of games and then ask patients to perform in sequence with prompting and motion tracking. Exercises include Frontal Bicep Curls, Arm Crosses, Press Ups, Arm Rotations, and Basketball Shots.
Sponsors
Study design
Eligibility
Inclusion criteria
* \>= 65 years of age * English-fluency in reading and speaking * Capacity to consent * Enrolled in HELP program * Attending physician confirms there are no medical contraindications to in-bed exercises
Exclusion criteria
* Unstable Psychiatric Illness * Unstable/Critically Ill Patients requiring ICU-level of care * Surgical tube present (e.g. JP drains) * Surgery during the hospitalization * Bed Rest Activity Order
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| % of Participants Who Reported "Yes" to Enjoying Their Work Out and Believing They Benefited From the Activity for Intervention Group Questionnaire. | Collected daily at the end of each workout. Survey responses were averaged for each participant. | % Of participants who reported "yes" to enjoying their work out and believed they benefited from the activity. These are two questions from the survey that were combined. Scale includes "Yes", "Maybe", "No" as possible responses. |
| Mean Software Utilization Time for Intervention Group (Change is Being Assessed) | Collected daily throughout duration of patient hospitalization, usually 1-2 weeks, Daily minutes were averaged over sessions | Mean Software Utilization Time for Intervention Group was calculated by taking the mean of daily minutes per exercise session per participant, and then calculating the mean minutes utilization time for all participants. |
| Average Exercise Repetitions Completed for Intervention Group | Collected daily throughout duration of patient hospitalization, usually 1-2 weeks | Completed exercise repetitions per patient were calculated by taking the mean of each participant's daily exercise repetitions and then calculating a mean of all participants. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Average Change in Activity Measure for Post Acute Care (AMPAC) Scores | Collected daily throughout duration of patient hospitalization, usually 1-2 weeks, Daily scores were averaged | Activity Measure for Post Acute Care (AMPAC) scores done by nurses twice daily (Score ranging from 0 to 24 with higher being better) |
| Length of Hospital Stay | Collected at the time of discharge of patient hospitalization, usually 1-2 weeks | — |
| Discharged Home | Collected at time of discharge, usually 1-2 weeks | Number of Participants with discharged home (as opposed to rehab, SNF) |
Countries
United States
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 24 Participants |
| Age, Categorical Between 18 and 65 years | 0 Participants |
| Age, Continuous | 77.1 years STANDARD_DEVIATION 6.6 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 2 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 20 Participants |
| Region of Enrollment United States | 14 participants |
| Sex: Female, Male Female | 5 Participants |
| Sex: Female, Male Male | 8 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 10 | 0 / 14 |
| other Total, other adverse events | 0 / 10 | 0 / 14 |
| serious Total, serious adverse events | 0 / 10 | 0 / 14 |